A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes

A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes

Bibliographic Details
Main Authors:	Francesco Schettini, Fara Brasó-Maristany, Nicole M. Kuderer, Aleix Prat
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-07-01
Series:	npj Breast Cancer
Online Access:	https://doi.org/10.1038/s41523-022-00451-9

Similar Items

Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report
by: Francesco Schettini, et al.
Published: (2022-11-01)

Dissecting the biological heterogeneity of HER2-positive breast cancer
by: Francesco Schettini, et al.
Published: (2021-10-01)

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
by: Laura Díaz-Gil, et al.
Published: (2021-10-01)

Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
by: Fara Brasó-Maristany, et al.
Published: (2021-09-01)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer
by: Olga Martínez-Sáez, et al.
Published: (2020-05-01)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
by: Gaia Griguolo, et al.
Published: (2021-02-01)

Gene expression profiles of breast cancer metastasis according to organ site
by: Fara Brasó‐Maristany, et al.
Published: (2022-01-01)

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy
by: Nuria Chic, et al.
Published: (2021-07-01)

A Simple Method for Robust and Accurate Intrinsic Subtyping of Breast Cancer
by: Mehdi Hamaneh, et al.
Published: (2023-03-01)

Intrinsic subtypes and bladder cancer metastasis
by: David J. McConkey, et al.
Published: (2016-10-01)

Associations of genetic susceptibility to 16 cancers with risk of breast cancer overall and by intrinsic subtypes
by: Jungyoon Choi, et al.
Published: (2022-01-01)

Is There a Correlation between Multiparametric Assessment in Ultrasound and Intrinsic Subtype of Breast Cancer?
by: Magdalena Gumowska, et al.
Published: (2021-11-01)

Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype
by: Yoo Chong, et al.
Published: (2011-10-01)

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
by: Olga Martínez-Sáez, et al.
Published: (2021-02-01)

Intrinsic tumor subtype and diagnostic performance of conventional breast imaging technique for the detection of unifocal breast cancer
by: C. Stanciu Pop, et al.
Published: (2021-04-01)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
by: Wataru Goto, et al.
Published: (2018-11-01)

Novel Integrative Genomics Approach for Associating GWAS Information with Intrinsic Subtypes of Breast Cancer
by: Chindo Hicks, et al.
Published: (2013-01-01)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2019-09-01)

Phase separation driven by interchangeable properties in the intrinsically disordered regions of protein paralogs
by: Shih-Hui Chiu, et al.
Published: (2022-04-01)

Intrinsic Subtypes and Androgen Receptor Gene Expression in Primary Breast Cancer. A Meta-Analysis
by: Paola Cruz-Tapias, et al.
Published: (2021-08-01)

Hormonal modulation of breast cancer gene expression: implications for intrinsic subtyping in pre-menopausal women
by: Sarah M Bernhardt, et al.
Published: (2016-11-01)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
by: Atif Ali Hashmi, et al.
Published: (2018-01-01)

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
by: Francesco Schettini, et al.
Published: (2021-01-01)

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
by: Aleix Prat, et al.
Published: (2022-01-01)

Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
by: Francesco Schettini, et al.
Published: (2023-04-01)

Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy
by: Tomás Pascual, et al.
Published: (2024-03-01)

HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping
by: Coralia Bueno Muiño, et al.
Published: (2022-01-01)

Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells
by: Jacquelyn J. Bower, et al.
Published: (2017-03-01)

Green Urban Interchanges: Stakeholder and User Perspectives
by: Nathanail Eftihia, et al.
Published: (2018-09-01)

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.
by: Delphine Hequet, et al.
Published: (2017-01-01)

Subtypes of breast cancer
by: D. D. Pak, et al.
Published: (2014-07-01)

Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden
by: Henrik Lindman, et al.
Published: (2022-09-01)

ELMO: An Efficient Logistic Regression-Based Multi-Omic Integrated Analysis Method for Breast Cancer Intrinsic Subtypes
by: Yexian Zhang, et al.
Published: (2020-01-01)

The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
by: Heloisa Helena Milioli, et al.
Published: (2015-01-01)

The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients.
by: Moo Hyun Lee, et al.
Published: (2016-01-01)

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
by: Charlotte Levin Tykjær Jørgensen, et al.
Published: (2021-03-01)

OSNA Total Tumor Load for the Prediction of Axillary Involvement in Breast Cancer Patients: Should We use Different Thresholds According to the Intrinsic Molecular Subtype? MOTTO Study
by: L Bernet, et al.
Published: (2023-07-01)

Subtypes of Breast Cancer in Northern IndiaAn Immunohistomolecular Subtypes of Invasive Breast Cancer
by: AMIT KUMAR SINHA, et al.
Published: (2020-10-01)

A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesResearch in context
by: Benedetta Conte, et al.
Published: (2024-04-01)

Interchangeability of drugs in Peru: current outlook and future perspectives
by: Enma Perez-Chauca, et al.
Published: (2021-08-01)